Cadence Pharmaceuticals, Inc. (NASDAQ:CADX)

CAPS Rating: 1 out of 5

A biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting.

Recs

0
Player Avatar Fiskhus (71.98) Submitted: 8/3/2012 7:59:56 AM : Outperform Start Price: $4.10 CADX Score: -4.51

T$x Up & Buy

Featured Broker Partners


Advertisement